Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 10

1.

Transforming activities of the NUP98-KMT2A fusion gene associated with myelodysplasia and acute myeloid leukemia.

Fisher JN, Thanasopoulou A, Juge S, Tzankov A, Bagger FO, Mendez MA, Peters AHFM, Schwaller J.

Haematologica. 2019 Sep 26. pii: haematol.2019.219188. doi: 10.3324/haematol.2019.219188. [Epub ahead of print]

2.

Dasatinib and navitoclax act synergistically to target NUP98-NSD1+/FLT3-ITD+ acute myeloid leukemia.

Kivioja JL, Thanasopoulou A, Kumar A, Kontro M, Yadav B, Majumder MM, Javarappa KK, Eldfors S, Schwaller J, Porkka K, Heckman CA.

Leukemia. 2019 Jun;33(6):1360-1372. doi: 10.1038/s41375-018-0327-2. Epub 2018 Dec 19.

PMID:
30568173
3.

Generation of a Selective Small Molecule Inhibitor of the CBP/p300 Bromodomain for Leukemia Therapy.

Picaud S, Fedorov O, Thanasopoulou A, Leonards K, Jones K, Meier J, Olzscha H, Monteiro O, Martin S, Philpott M, Tumber A, Filippakopoulos P, Yapp C, Wells C, Che KH, Bannister A, Robson S, Kumar U, Parr N, Lee K, Lugo D, Jeffrey P, Taylor S, Vecellio ML, Bountra C, Brennan PE, O'Mahony A, Velichko S, Müller S, Hay D, Daniels DL, Urh M, La Thangue NB, Kouzarides T, Prinjha R, Schwaller J, Knapp S.

Cancer Res. 2015 Dec 1;75(23):5106-5119. doi: 10.1158/0008-5472.CAN-15-0236. Epub 2015 Nov 9.

4.

Potent co-operation between the NUP98-NSD1 fusion and the FLT3-ITD mutation in acute myeloid leukemia induction.

Thanasopoulou A, Tzankov A, Schwaller J.

Haematologica. 2014 Sep;99(9):1465-71. doi: 10.3324/haematol.2013.100917. Epub 2014 Jun 20.

5.

PFI-1, a highly selective protein interaction inhibitor, targeting BET Bromodomains.

Picaud S, Da Costa D, Thanasopoulou A, Filippakopoulos P, Fish PV, Philpott M, Fedorov O, Brennan P, Bunnage ME, Owen DR, Bradner JE, Taniere P, O'Sullivan B, Müller S, Schwaller J, Stankovic T, Knapp S.

Cancer Res. 2013 Jun 1;73(11):3336-46. doi: 10.1158/0008-5472.CAN-12-3292. Epub 2013 Apr 10.

6.

Silencing of CCDC6 reduces the expression of 14-3-3σ in colorectal carcinoma cells.

Thanasopoulou A, Xanthopoulou AG, Anagnostopoulos AK, Konstantakou EG, Margaritis LH, Papassideri IS, Stravopodis DJ, Tsangaris GT, Anastasiadou E.

Anticancer Res. 2012 Mar;32(3):907-13.

PMID:
22399611
7.

Loss of CCDC6 affects cell cycle through impaired intra-S-phase checkpoint control.

Thanasopoulou A, Stravopodis DJ, Dimas KS, Schwaller J, Anastasiadou E.

PLoS One. 2012;7(2):e31007. doi: 10.1371/journal.pone.0031007. Epub 2012 Feb 17.

8.

The proteome of normal human chorionic villus sampling cells.

Xanthopoulou AG, Anagnostopoulos AK, Thanasopoulou A, Anastasiadou E, Sifakis S, Siafaka-Kapadai A, Tsangaris GT.

In Vivo. 2011 Nov-Dec;25(6):945-61.

PMID:
22021689
9.

Thymidylate synthase inhibition induces p53-dependent and p53-independent apoptotic responses in human urinary bladder cancer cells.

Stravopodis DJ, Karkoulis PK, Konstantakou EG, Melachroinou S, Thanasopoulou A, Aravantinos G, Margaritis LH, Anastasiadou E, Voutsinas GE.

J Cancer Res Clin Oncol. 2011 Feb;137(2):359-74. doi: 10.1007/s00432-010-0891-y. Epub 2010 Apr 28.

PMID:
20425122
10.

Gelsolin expression is necessary for the development of modelled pulmonary inflammation and fibrosis.

Oikonomou N, Thanasopoulou A, Tzouvelekis A, Harokopos V, Paparountas T, Nikitopoulou I, Witke W, Karameris A, Kotanidou A, Bouros D, Aidinis V.

Thorax. 2009 Jun;64(6):467-75. doi: 10.1136/thx.2008.107946. Epub 2009 Feb 12.

PMID:
19213772

Supplemental Content

Loading ...
Support Center